Hoth Therapeutics Procures Full Licensing Rights for BioLexa Platform, Atopic Dermatitis Treatment

BioLexa is targeting the global pediatric eczema market NEW YORK, May 18, 2020 -- (Healthcare Sales & Marketing Network) -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced today that the company has obtained exclusi... Biopharmaceuticals, Dermatology, Licensing Hoth Therapeutics, Chelexa Biosciences, BioLexa, atopic dermatitis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news